High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: Relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors

Cancer

Volumn 94, Issue 9, 2002, Pages 2454-2465

  Kouvaraki, Maria ^a   Gorgoulis, Vassilis G ^a,b   Rassidakis, George Z ^a   Liodis, Petros ^a   Markopoulos, Christos ^a   Gogas, John ^a   Kittas, Christos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Laiko General Hospital ^*  (Greece)

Author keywords

16q22.1; Breast carcinoma; E cadherin; Ki 67; p27; Ploidy

Indexed keywords

PROTEIN P27; UVOMORULIN;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INHIBITION; CANCER INVASION; CANCER STAGING; CARCINOMA CELL; CELL CYCLE; CELL LABELING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; MUTATION; PLOIDY; PRIORITY JOURNAL; TUMOR GROWTH;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL CYCLE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MICROSATELLITE REPEATS; NEOPLASM INVASIVENESS; PLOIDIES; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0036569518     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10505     Document Type: Article

References (76)

1. Breast cancer epidemiology
2. Genetic alterations in breast cancer
3. Somatic genetic changes in human breast cancer
4. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas
5. G1 phase progression: Cycling on cue
6. Formation of p27-CDK complexes during the human mitotic cell cycle
7. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
8. Regulation of the cdk inhibitor p27 and its deregulation in cancer
9. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma
10. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas
11. p27/Kip1 mutation found in breast cancer
12. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
13. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers
14. Deregulated expression of p27(Kip1) in human breast cancers
15. p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
16. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
17. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
18. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
19. Prognostic role of p27Kip1 and apoptosis in human breast cancer
20. Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node-positive breast cancer
21. p27(kip1) expression in breast carcinomas: An immunohistochemical study on 512 patients with long-term follow-up
22. Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast
23. E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)
24. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1)
25. The genes for the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome
26. Cadherin cell adhesion receptors as a morphogenetic regulator
27. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer
28. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
29. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas
30. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma
31. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers
32. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain
33. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements
34. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer
35. Transcriptional defects underlie loss of E-cadherin expression in breast cancer
36. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online
37. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
38. E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration
39. E-cadherin and alpha-catenin expression in human esophageal cancer
40. E-cadherin: A differentiation marker in thyroid malignancies
41. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
42. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: Correlation with proliferative activity, ploidy and hormonal status of the tumors
43. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts
44. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells
45. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
46. Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition
47. A cell cycle-regulated inhibitor of cyclin-dependent kinases
48. The p53 pathway
49. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
50. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression
51. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
52. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
53. Specific protection against breast cancers by cyclin D1 ablation
54. CDK inhibitors: Positive and negative regulators of G1-phase progression
55. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4
56. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes
57. The p21(Cip1) and p27(Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts
58. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence
59. Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis
60. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells
61. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia
62. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma
63. Immunophenotypic and prognostic analysis of E-cadherin and betacatenin expression during breast carcinogenesis and tumour progression: A comparative study with CD44
64. Expression of E-cadherin and catenins in invasive mammary carcinomas
65. An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene
66. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases
67. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers
68. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer
69. E-cadherin inactivation in lobular carcinoma in situ of the breast: An early event in tumorigenesis
70. Frequent alterations in E-cadherin and alpha- and betacatenin expression in human breast cancer cell lines
71. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo
72. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
73. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas
74. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
75. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas
76. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma